• OPEN AN ACCOUNT
Indian Indices
Sensex
73,326.48 -526.42
( -0.71%)
Global Indices
Nasdaq
52,511.77 524.74
(1.01%)
Dow Jones
7,731.20 19.47
(0.25%)
Hang Seng
64,728.80 653.38
(1.02%)
Nikkei 225
10,731.75 -32.94
(-0.31%)
Forex
USD-INR
94.90 0.12
(0.13%)
EUR-INR
106.44 -0.03
(-0.02%)
GBP-INR
126.38 0.12
(0.10%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Arihant Academy Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
77878
INE0NCC01015
27.6966904
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ARIHANTACA
30.26
278.54
EPS(TTM)
Face Value()
Div & Yield %
7.6
10
0.44
 

Symbiotec Pharmalab surges after Pithampur facility gets EIR from US FDA
Sep 29,2026

The American drug regulatory has issued the said EIR report with a voluntary action indicated (VAI) status.

The US FDA had conducted an inspection at the company’s manufacturing facility at Pithampur, from 10 August 2026 to 14 August 2026.

Symbiotec Pharmalab is a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across organic chemistry, biotechnology and complex injectables.

The company had reported 52.8% fall in consolidated net profit to Rs 14.1 crore despite a 7% rise in revenue from operations to Rs 218.2 crore in Q1 FY27 as compared with Q1 FY26.